<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01920048</url>
  </required_header>
  <id_info>
    <org_study_id>ISRCTN45979711</org_study_id>
    <secondary_id>ISRCTN45979711</secondary_id>
    <nct_id>NCT01920048</nct_id>
  </id_info>
  <brief_title>Study of Efficacy and Safety of Percutaneous Coronary Intervention to Improve Survival in Heart Failure</brief_title>
  <acronym>REVIVED-BCIS2</acronym>
  <official_title>REVascularisation for Ischaemic VEntricular Dysfunction (REVIVED): a Randomized Comparison of Percutaneous Coronary Intervention (With Optimal Medical Therapy) Versus Optimal Medical Therapy Alone for Treatment of Heart Failure Secondary to Coronary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>King's College London</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute for Health Research, United Kingdom</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>London School of Hygiene and Tropical Medicine (Clinical Trials Unit)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of York</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>King's College London</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess whether percutaneous coronary intervention (angioplasty of the heart
      arteries) can improve survival and reduce hospitalization in patients with heart failure due
      to coronary disease, who have been treated with the best contemporary medical therapy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2013</start_date>
  <completion_date type="Anticipated">March 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>All-cause death or Hospitalization for Heart Failure</measure>
    <time_frame>1 to 66 months (min follow-up duration: 24 months)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life Scores and Functional Status</measure>
    <time_frame>6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Left Ventricular Ejection Fraction</measure>
    <time_frame>6 months, 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular Death</measure>
    <time_frame>1 to 66 months (min follow-up duration: 24 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Appropriate Implantable Cardioverter Defibrillator Therapy</measure>
    <time_frame>6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Myocardial Infarction</measure>
    <time_frame>1 to 66 months (min follow-up duration: 24 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Unplanned further revascularization</measure>
    <time_frame>1 to 66 months (min follow-up duration: 24 months)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain-type Natriuretic Peptide level</measure>
    <time_frame>6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Major Bleeding</measure>
    <time_frame>6 months, 1 year, 2 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Health Service Resource Use</measure>
    <time_frame>1 to 66 months (min follow-up duration: 24 months)</time_frame>
    <description>Health Economic Analysis</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">700</enrollment>
  <condition>Ischemic Cardiomyopathy</condition>
  <arm_group>
    <arm_group_label>Percutaneous Coronary Intervention and Optimal Medical Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Optimal Medical Therapy alone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Percutaneous Coronary Intervention</intervention_name>
    <arm_group_label>Percutaneous Coronary Intervention and Optimal Medical Therapy</arm_group_label>
    <other_name>Coronary angioplasty/stents</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Drug Therapy for Heart Failure</intervention_name>
    <description>The optimal combination of drugs and doses for each patient will be individualized and will be determined by his/her physician, in accordance with local and international clinical practice guidelines</description>
    <arm_group_label>Percutaneous Coronary Intervention and Optimal Medical Therapy</arm_group_label>
    <arm_group_label>Optimal Medical Therapy alone</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Device Therapy for Heart Failure</intervention_name>
    <description>The optimal device therapy for each patient will be individualized and will be determined by his/her physician, in accordance with local and international clinical practice guidelines. In most cases the device will be an Implantable Cardioverter Defibrillator and/or Cardiac Resynchronization Therapy.</description>
    <arm_group_label>Percutaneous Coronary Intervention and Optimal Medical Therapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        ALL of the following:

          1. Poor left ventricular function (EFâ‰¤35%)

          2. Extensive coronary disease

          3. Viability in at least 4 dysfunctional segments that can be revascularised by PCI

        Exclusion Criteria:

          1. Myocardial infarction &lt; 4 weeks prior to randomisation (clinical definition)

          2. Decompensated heart failure requiring inotropic support, invasive or non-invasive
             ventilation or Intra-aortic Balloon Pump/left ventricular assist device therapy &lt;72
             hours prior to randomization

          3. Sustained Ventricular Tachycardia/Ventricular Fibrillation or appropriate Implantable
             Cardioverter Defibrillator discharges &lt;72 hours prior to randomization

          4. Valve disease requiring intervention

          5. Contraindications to percutaneous coronary intervention

          6. Age &lt;18 yrs

          7. Estimated Glomerular Filtration Rate &lt; 25 ml/min, unless established on dialysis

          8. Women who are pregnant

          9. Previously enrolled in REVIVED-BCIS2 or current enrollment in other study that may
             affect REVIVED-BCIS2 outcome data

         10. Life expectancy &lt; 1 yr due to non-cardiac pathology
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Divaka Perera, MB BChir, MA, MD, FRCP</last_name>
    <role>Principal Investigator</role>
    <affiliation>King's College London</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Richard Evans</last_name>
    <phone>+44 20 7927 2665</phone>
    <email>Richard.Evans@lshtm.ac.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rosemary Knight</last_name>
    <phone>+44 20 7927 2473</phone>
    <email>Rosemary.Knight@lshtm.ac.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Birmingham Heartlands Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B9 5SS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alan Chung</last_name>
      <email>alan.chung@heartofengland.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <zip>BH7 7DW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Kennard</last_name>
      <email>Cardiac.Research@rbch.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Infirmary of Edinburgh</name>
      <address>
        <city>Edinburgh</city>
        <zip>EH16 4SA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Belinda Rif</last_name>
      <email>belinda.rif@nhslothian.scot.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Golden Jubilee National Hospital</name>
      <address>
        <city>Glasgow</city>
        <zip>G81 4DY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marion McAdam</last_name>
      <email>Marion.McAdam@gjnh.scot.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Kettering General Hospital</name>
      <address>
        <city>Kettering</city>
        <zip>NN16 8UZ</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charmaine Beirnes</last_name>
      <email>Charmaine.Beirnes@kgh.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Leeds General Infirmary</name>
      <address>
        <city>Leeds</city>
        <zip>LS1 3EX</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michelle Anderson</last_name>
      <email>michelle.anderson13@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Glenfield Hospital</name>
      <address>
        <city>Leicester</city>
        <zip>LE3 9QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jo Hughes</last_name>
      <email>joanna.hughes@uhl-tr.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Liverpool Chest and Heart Hospital</name>
      <address>
        <city>Liverpool</city>
        <zip>L14 3PE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jan Barton</last_name>
      <email>Janet.Barton@lhch.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Free Hospital</name>
      <address>
        <city>London</city>
        <zip>NW3 2QG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angelique Smit</last_name>
      <email>angelique.smit@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's and St Thomas' Hospital</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lucy Clack</last_name>
      <phone>+44 20 7188 6271</phone>
      <email>Lucy.Clack@gstt.nhs.uk</email>
    </contact>
    <contact_backup>
      <last_name>Sophie Jones</last_name>
      <phone>+44 20 7188 7188</phone>
      <email>Sophie.Jones@gstt.nhs.uk</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>King's College Hospital</name>
      <address>
        <city>London</city>
        <zip>SE5 9RS</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ava Williams</last_name>
      <email>ava.williams@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Manchester Royal Infirmary</name>
      <address>
        <city>Manchester</city>
        <zip>M13 9WL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sarah Evans</last_name>
      <email>sarah.evansmhc@cmft.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>James Cook University Hospital</name>
      <address>
        <city>Middlesbrough</city>
        <zip>TS4 3BW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Cath Richardson</last_name>
      <email>Catherine.Richardson@stees.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle</city>
        <zip>NE7 7DN</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alla Narytnyk</last_name>
      <email>alla.narytnyk@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Alexandra Hospital</name>
      <address>
        <city>Portsmouth</city>
        <zip>PO6 3LY</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Serena Howe</last_name>
      <email>Serena.Howe2@porthosp.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Northern General Hospital</name>
      <address>
        <city>Sheffield</city>
        <zip>S5 7AU</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joyce Fofie</last_name>
      <email>Joyce.Fofie@sth.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Judy Radmore</last_name>
      <email>Judith.Radmore@uhs.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Lister Hospital</name>
      <address>
        <city>Stevenage</city>
        <zip>SG1 4AB</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Claire Barratt</last_name>
      <email>claire.barratt@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Sunderland Royal Hospital</name>
      <address>
        <city>Sunderland</city>
        <zip>SR4 7TP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pauline Oates</last_name>
      <email>Pauline.Oates@chsft.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Pinderfields Hospital</name>
      <address>
        <city>Wakefield</city>
        <zip>WF1 4DG</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Judith Wright</last_name>
      <email>Judith.Wright2@midyorks.nhs.uk</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>New Cross Hospital</name>
      <address>
        <city>Wolverhampton</city>
        <zip>WV10 0QP</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andrew Smallwood</last_name>
      <email>andy.smallwood@nhs.net</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Wycombe Hospital</name>
      <address>
        <city>Wycombe</city>
        <zip>HP11 2TT</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Nicola Bowers</last_name>
      <email>Nicola.Bowers@buckshealthcare.nhs.uk</email>
    </contact>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>July 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2013</study_first_submitted>
  <study_first_submitted_qc>August 8, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 9, 2013</study_first_posted>
  <last_update_submitted>July 20, 2016</last_update_submitted>
  <last_update_submitted_qc>July 20, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>King's College London</investigator_affiliation>
    <investigator_full_name>Divaka Perera</investigator_full_name>
    <investigator_title>Consultant Cardiologist and Reader in Interventional Cardiology</investigator_title>
  </responsible_party>
  <keyword>Heart Failure</keyword>
  <keyword>Ventricular Dysfunction</keyword>
  <keyword>Ischemic Cardiomyopathy</keyword>
  <keyword>Ischemic Heart Disease</keyword>
  <keyword>Revascularization</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Randomized Control Trial</keyword>
  <keyword>Implantable Cardioverter Defibrillator</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
    <mesh_term>Ventricular Dysfunction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

